Valuation: Bayer AG

Market Cap 44.31B 49.81B 41.41B 37.75B 70.85B 4,799B 71.9B 500B 194B 2,448B 187B 183B 7,876B P/E 2026 *
20.6x
P/E 2027 * 14.8x
Enterprise Value 74.26B 83.49B 69.4B 63.28B 119B 8,044B 121B 838B 325B 4,103B 313B 307B 13,201B EV / Sales 2026 *
1.62x
EV / Sales 2027 * 1.51x
Free-Float
99.99%
Yield 2026 *
0.35%
Yield 2027 * 1.23%
1 day-5.68%
1 week-8.41%
Current month-5.68%
1 month-7.29%
3 months-5.36%
6 months+15.86%
Current year+22.93%
1 week 45.46
Extreme 45.46
50.92
1 month 45.46
Extreme 45.46
50.92
Current year 33.13
Extreme 33.13
53.76
1 year 25.87
Extreme 25.87
53.76
3 years 18.22
Extreme 18.222
53.76
5 years 18.22
Extreme 18.222
67.84
10 years 18.22
Extreme 18.222
123.12
Manager TitleAgeSince
Chief Executive Officer 60 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 61 2017-03-31
Chairman 68 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-5.68%-8.41% - - 53.49B
-0.62%-0.10%+50.70%+114.07% 1,031B
-2.30%-3.90%+39.50%+66.07% 638B
-0.63%-1.94%+12.26%+74.38% 462B
-1.03%-2.88%+71.35%+39.69% 359B
-0.03%-3.91%+34.28%+39.35% 335B
-1.58%+0.39%+17.92%+25.77% 273B
-2.02%-3.20%+7.60%+8.38% 253B
-3.38%+0.29%+44.32%+51.54% 228B
-1.04%-2.56%+32.88%+96.82% 185B
Average -1.23%-0.36%+34.53%+57.34% 418.21B
Weighted average by Cap. -0.40%-0.35%+38.05%+69.18%

Financials

2026 *2027 *
Net sales 45.83B 51.53B 42.83B 39.05B 73.28B 4,964B 74.37B 517B 200B 2,532B 193B 189B 8,147B 47.06B 52.91B 43.98B 40.1B 75.25B 5,098B 76.37B 531B 206B 2,600B 199B 194B 8,366B
Net income 2.14B 2.41B 2B 1.82B 3.42B 232B 3.47B 24.16B 9.35B 118B 9.03B 8.83B 380B 2.94B 3.31B 2.75B 2.51B 4.7B 318B 4.77B 33.19B 12.85B 162B 12.4B 12.13B 523B
Net Debt 29.96B 33.68B 27.99B 25.53B 47.9B 3,245B 48.61B 338B 131B 1,655B 126B 124B 5,325B 26.84B 30.17B 25.08B 22.87B 42.91B 2,907B 43.55B 303B 117B 1,483B 113B 111B 4,771B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
26-10-01 €45.52 -5.68% 3,791
26-09-30 €48.26 -1.15% 787
26-09-29 €48.82 -3.40% 5,980
26-09-28 €50.54 +1.45% 2,561
26-09-25 €49.82 +0.08% 4,068
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
45.40EUR
Average target price
58.22EUR
Spread / Average Target
+28.24%

Quarterly revenue - Rate of surprise